United States · FDA National Drug Code directory

Sephience

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
60468-007_4031b751-a798-3024-e063-6294a90ac2b4
Product NDC
60468-007
Form
POWDER
Composition / generic term
SEPIAPTERIN
Labeler
allphamed Pharbil Arzneimittel GmbH
Marketing category
NDA
Marketing start / end (source format)
20250728
Source listing expiry
20261231

Source-listed ingredients

  • SEPIAPTERIN — 250 mg/1

These values do not establish equivalence or a dose recommendation.

Packages

  • 30 PACKET in 1 CARTON (60468-007-03) / 1 POWDER in 1 PACKET (60468-007-01) · 60468-007-03

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →